Morgan Stanley’s Quince Therapeutics QNCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.1K Sell
4,302
-49,272
-92% -$81.3K ﹤0.01% 6941
2025
Q1
$71.3K Sell
53,574
-23,127
-30% -$30.8K ﹤0.01% 6155
2024
Q4
$143K Buy
76,701
+68,179
+800% +$127K ﹤0.01% 5913
2024
Q3
$6.62K Hold
8,522
﹤0.01% 6832
2024
Q2
$6.39K Buy
8,522
+122
+1% +$92 ﹤0.01% 6792
2024
Q1
$8.9K Sell
8,400
-9,774
-54% -$10.4K ﹤0.01% 6754
2023
Q4
$19.1K Buy
18,174
+8,632
+90% +$9.06K ﹤0.01% 6676
2023
Q3
$10.7K Buy
9,542
+2,293
+32% +$2.57K ﹤0.01% 6712
2023
Q2
$10.9K Sell
7,249
-2,445
-25% -$3.68K ﹤0.01% 6789
2023
Q1
$15.1K Sell
9,694
-2,065
-18% -$3.22K ﹤0.01% 6735
2022
Q4
$7.5K Sell
11,759
-214,890
-95% -$137K ﹤0.01% 7036
2022
Q3
$302K Sell
226,649
-308,080
-58% -$411K ﹤0.01% 5525
2022
Q2
$1.19M Sell
534,729
-274,623
-34% -$610K ﹤0.01% 4909
2022
Q1
$5.01M Sell
809,352
-217,055
-21% -$1.34M ﹤0.01% 3683
2021
Q4
$13M Buy
1,026,407
+992,154
+2,897% +$12.5M ﹤0.01% 2637
2021
Q3
$3.14M Sell
34,253
-1,322
-4% -$121K ﹤0.01% 4183
2021
Q2
$1.89M Buy
35,575
+14,139
+66% +$750K ﹤0.01% 4678
2021
Q1
$773K Sell
21,436
-140,163
-87% -$5.05M ﹤0.01% 4889
2020
Q4
$4.49M Buy
161,599
+149,140
+1,197% +$4.14M ﹤0.01% 3376
2020
Q3
$623K Sell
12,459
-1,961
-14% -$98.1K ﹤0.01% 4530
2020
Q2
$668K Buy
14,420
+4,091
+40% +$190K ﹤0.01% 4447
2020
Q1
$471K Sell
10,329
-78,234
-88% -$3.57M ﹤0.01% 4411
2019
Q4
$4.97M Buy
88,563
+82,626
+1,392% +$4.64M ﹤0.01% 3214
2019
Q3
$148K Sell
5,937
-40,412
-87% -$1.01M ﹤0.01% 5287
2019
Q2
$1.97M Buy
+46,349
New +$1.97M ﹤0.01% 3780